The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N06 | Psychoanaleptics | |
3
|
N06A | Antidepressants | |
4
|
N06AX | Other antidepressants | |
5
|
N06AX16 | Venlafaxine |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 100 mg |
| Active Ingredient |
|---|
|
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
| Document | Type | Information Source | |
|---|---|---|---|
| DEPEFEX Prolonged-release capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| EFEXOR XL Prolonged-release capsule, hard | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| EFFEXOR XR Extended-release capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| MAJOVEN Prolonged-release capsule, hard | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| SUNVENIZ XL Prolonged-release tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VENLABLUE XL Prolonged-release capsule, hard | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| VENLOR XR Capsule | MPI, US: SPL/PLR | Web Search | |
| VENSIR Prolonged release capsule, hard | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| VIEPAX Prolonged-release tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.